Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F128 - Dermatologic Side Effects of Anticancer Drugs in 2018: What You Need to Know

Monday, February 19; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Diagnose the most common and clinically significant dermatologic adverse events of new cancer therapies.
  • Develop preventive and treatment strategies for skin, hair, and nail events to novel oncology agents.
  • Summarize the efficacy of interventions that mitigate adverse events in oncology.

Description

Of the 1.7 million people diagnosed with cancer every year, approximately 65% will receive a systemic treatment, including cytotoxic, targeted, or immunotherapeutic agent. These will frequently result in toxicities such as alopecia, rash, pruritus, and nail toxicities, all of which affect quality of life and the ability to receive life-saving or prolonging therapies. This session provides critical knowledge to diagnose, prevent, and treat dermatologic adverse events from novel anticancer agents.

Disclosures

  • Albert, Denise: no financial relationships exist with commercial interests.
  • Lacouture, Mario E., MD: Berg Pharma, LLC – I(Grants/Research Funding); Boehringer Ingelheim – C(H); Bristol-Myers Squibb – SP(Grants/Research Funding); Dignitana – A(H); foamix – A(H); Genentech, Inc. – C(H); Legacy – A(H); Novartis – C(H); Paxman – I(Grants/Research Funding); Quintiles Pharma – C(H); Roche Laboratories – C(H);
  • Larocca, Cecilia, MD: no financial relationships exist with commercial interests.
  • LeBoeuf, Nicole, MD: Bayer – Speaker/Faculty Education(H);
Schedule
Monday, February 19
1:00 PM
Dr. Lacouture / Supportive Oncodermatology
1:15 PM
Dr. LeBoeuf / Targeted Therapy
1:45 PM
Dr. Wu / Immune Checkpoint Inhibitors
2:15 PM
Dr. Lacouture / Scalp cooling and hair disorders
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 26A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Mario E. Lacouture, MD, FAAD
Speakers
  • Cecilia Larocca, MD, FAAD
  • Denise Albert
  • Nicole LeBoeuf, MD, FAAD